Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate

被引：25
|
作者：
Poggio, F. [1 ]
Tagliamento, M. [2 ,3 ]
Ceppi, M. [4 ]
Bruzzone, M. [4 ]
Conte, B. [1 ,2 ]
Fregatti, P. [5 ,6 ]
Punie, K. [7 ,8 ]
de Azambuja, E. [9 ]
Del Mastro, L. [2 ,10 ]
Lambertini, M. [2 ,11 ]
机构：
[1] IRCCS Osped Policlin San Martino, Oncol Med 2, Genoa, Italy
[2] Univ Genoa, Sch Med, Dept Internal Med & Med Specialties DiMI, Genoa, Italy
[3] Gustave Roussy, Dept Canc Med, Villejuif, France
[4] IRCCS Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy
[5] IRCCS Osped Policlin San Martino, Dept Surg, UOC Clin Chirurg Senol, Genoa, Italy
[6] Univ Genoa, Sch Med, Dept Integrated Diagnost Surg Sci, Genoa, Italy
[7] Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium
[8] Univ Hosp Leuven, Leuven Canc Inst, Multidisciplinary Breast Ctr, Leuven, Belgium
[9] Univ Libre Bruxelles ULB, Inst Jules Bordet, Brussels, Belgium
[10] IRCCS Osped Policlin San Martino, Breast Unit, Genoa, Italy
[11] IRCCS Osped Policlin San Martino, Dept Med Oncol, UOC Clin Oncol Med, Genoa, Italy
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 03期
关键词：
D O I：
10.1016/j.annonc.2021.11.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：347 / 349
页数：3
相关论文
共 50 条
  • [31] BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Sengoku, Norihiko
    Waraya, Mina
    Nishimiya, Hiroshi
    Katoh, Hirozhi
    Kikuchi, Mariko
    Minatani, Naoko
    Teraoka, Saeko
    Enomoto, Takumo
    Sato, Takeo
    Masahiko, Masahiko
    CANCER RESEARCH, 2015, 75
  • [32] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Nishimiya, Hiroshi
    Tanaka, Youko
    Minatani, Naoko
    Kikuchi, Mariko
    Shida, Akiko
    Waraya, Mina
    Katoh, Hiroshi
    Enomoto, Takumo
    Sengoku, Norihiko
    Kajita, Sabine
    Hoffman, Robert M.
    Watanabe, Masahiko
    PLOS ONE, 2016, 11 (12):
  • [33] THE GENE EXPRESSION PROFILE OF TRIPLE-NEGATIVE BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPY
    Philipovskiy, A.
    Gaur, S.
    Chambers, K.
    Gamez, R.
    McCallum, R.
    Kirken, R.
    Aguilera, R.
    Roy, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 440 - 440
  • [34] The response to neoadjuvant chemotherapy and prognosis of triple-negative breast cancer patients.
    Nakano, E.
    Hojo, T.
    Masumura, K.
    Kikuyama, M.
    Akashi, S.
    Kinoshita, T.
    CANCER RESEARCH, 2009, 69 (02) : 337S - 337S
  • [35] Neoadjuvant chemotherapy in HER2-positive and triple-negative breast cancer
    Goncalves, Anthony
    BULLETIN DU CANCER, 2016, 103 (06) : S76 - S89
  • [36] Androgen receptor expression and outcome of neoadjuvant chemotherapy in triple-negative breast cancer
    Di Leone, A.
    Fragomeni, S. M.
    Scardina, L.
    Ionta, L.
    Mule, A.
    Magno, S.
    Terribile, D.
    Masetti, R.
    Franceschini, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (04) : 1910 - 1915
  • [37] Residual cancer burden and neoangiogenesis after neoadjuvant chemotherapy in triple-negative breast cancer
    Miyashita, M.
    Sasano, H.
    Tamaki, K.
    Hirakawa, H.
    Ishida, T.
    Ohuchi, N.
    BREAST, 2017, 32 : S100 - S101
  • [38] A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer
    Li, Y.
    Xing, L.
    Yin, X.
    Li, H.
    Ren, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S50 - S51
  • [39] Neo-adjuvant Chemotherapy for triple-negative breast cancer: a place for platinum?
    Goncalves, Anthony
    BULLETIN DU CANCER, 2014, 101 (12) : 1063 - 1063
  • [40] Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy With Immunotherapy Result in Different Tumor Shrinkage Patterns in Triple-Negative Breast Cancer
    Zou, Jiachen
    Zhang, Liulu
    Chen, Yuanqi
    Lin, Yingyi
    Cheng, Minyi
    Zheng, Xingxing
    Zhuang, Xiaosheng
    Wang, Kun
    JOURNAL OF BREAST CANCER, 2024, 27 (01) : 27 - 36
12345